Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 7 analyst ratings
Strong Buy
Strong Buy 57%
Buy 43%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc. displays a promising financial outlook, with an enterprise value of approximately $430 million, suggesting potential long-term gains of 8-10 times the current share price, contingent on the success of its partnership with Novo Nordisk. The company is advancing a robust pipeline of product candidates targeting significant therapeutic areas, which could position SEP-631 to achieve blockbuster status akin to the successful Xolair medication, thereby significantly enhancing revenue generation potential. Furthermore, Septerna's innovative approach in the obesity treatment sector, combined with its proprietary platform, creates a compelling value proposition that may lead to substantial, low-risk commercial opportunities.

Bears say

Septerna Inc faces multiple risks that could negatively impact its stock performance, including potential delays in the clinical development of its key candidates, such as SEP-631, as well as setbacks in ongoing clinical trials. The company's partnership with Novo Nordisk introduces additional uncertainties, with risks pertaining to the strength and outcomes of their collaboration, which could affect the progression of their therapeutic portfolio. Furthermore, there are concerns regarding the ability to obtain regulatory approvals for its drug candidates, achieve satisfactory market penetration rates, and the possibility of long-term dilution affecting shareholder value.

Septerna Inc (SEPN) has been analyzed by 7 analysts, with a consensus rating of Strong Buy. 57% of analysts recommend a Strong Buy, 43% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 7 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.